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to those who discussed nothing. CONCLUSIONS: Most men and providers did not 
discuss disadvantages of PSA testing. Men with higher education, being older and 
having a unique personal provider were more likely to have discussed about PSA 
testing with their providers. Discussions with providers had a significant positive 
impact on PSA testing. Providers should discuss completely about PSA testing with 
men to help them in decision making.
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OBJECTIVES: Due to its chronic nature and the severity of its complications, diabetes 
has major clinical and financial impacts on patients and health care. Evidence sug-
gests that community-based disease management models have the ability to improve 
outcomes for patients with diabetes. Scott & White Health Plan (SWHP) offers a medi-
cation management program (MMP) in which eligible members with diabetes receive 
monthly educational visits with a pharmacist, anti-diabetic medications, and testing 
supplies at no cost. This study aims to evaluate the clinical impact of the diabetes 
MMP offered by SWHP by comparing long-term glycemic control in diabetic patients 
who are enrolled in the MMP to those not enrolled. METHODS: Diabetic patients aged 
18 to 61 at time of MMP enrollment (index) with continuous enrollment in SWHP one 
year prior and four years post-index were included. Patients in MMP must be enrolled 
for four years, with control subjects receiving standard diabetes care during this time. 
Control subjects were matched 2:1 on age, gender, diabetes type (I or II), insulin use, 
and physical comorbidity. HbA1c data were obtained from medical records. Bivariate 
analyses assessed differences in patient characteristics by group. RESULTS: A total 
of 73 diabetic patients were matched with standard care patients for a combined 
sample of 219, with 56% female and mean age 52 years (SD= 5.7). Although MMP 
patients had greater baseline HbA1c (median: 8.8% MMP vs. 7.4% control; p< 0.01 per 
Wilcoxon rank-sum test), they experienced a greater reduction in HbA1c after 4 years 
(median reduction: 1.0% MMP vs. 0.1% control, p< 0.01). Eighteen (25%) MMP patients 
who were uncontrolled at baseline were at or below goal by the end of the study 
period. CONCLUSIONS: Participation of diabetic patients in the MMP demonstrated 
an improvement in glycemic control, supporting the idea that ambulatory pharma-
cists can be effective in community-based diabetes management.
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OBJECTIVES: Objective of this study is to assess a trend of physician visit among 
individuals who were detected as hepatic dysfunction by the annual health checkup 
(Kenshin) which is implemented in Japan. METHODS: This is a retrospective cohort 
study using Japan Medical Data Center (JMDC) database. Annual health checkup 
data in 2012 and the associated claims data were merged by unique identifiers. 
Individuals (18≤ age≤ 64) with ALT> 30(IU/L) as hepatic dysfunction were identified. 
The proportion of individuals who visited a physician office after the annual health 
checkup for liver related diagnosis up to month 3,6,9 and 12 from the date of the 
annual health checkup was evaluated. The number of visits associated with liver 
related diagnosis and confirmed diagnosis with liver-related disease by gender and 
age was assessed. The cox proportional hazard regression model was used to evalu-
ate variables associated with a physician visit. RESULTS: 353,384 individuals were 
received hepatic function tests at the annual health checkup in 2012. 57,059 indi-
viduals were identified ALT> 30(IU/L) without any liver related diagnosis in preceding 
12 months of the annual health checkup. Among them, the cumulative proportion of 
individuals who visited physician office was 4%(month 3), 11%(month 6), 20%(month 
9), and 30%(month 12). 4,379(8%) of individuals were confirmed with liver related 
diagnosis at month 12. Fatty liver was major diagnosis followed by alcoholic hepatic 
disease, virus hepatitis, hepatic fibrosis or cirrhosis and liver cancer. Individuals 
with higher ALT values, older age, and female are more likely to visit physician’s 
office after the annual health checkup. CONCLUSIONS: One in six individuals was 
newly detected with hepatic dysfunction at the annual checkup. Despite of the 
serious consequence of liver related diseases, small number of individuals with 
hepatic dysfunctions detected by the annual health checkup visited physician office 
for further evaluation of the diagnosis.
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OBJECTIVES: Diagnosis of children with attention-deficit/hyperactivity disorder 
(ADHD) is increasing. Recent studies have shown a tendency for younger children 
in a school cohort being diagnosed with the condition, suggesting the diagnosis 
is associated with immaturity. Given potential sequelae of treatment, there is a 
great need to evaluate potential misdiagnosis. The present study sought to identify 
characteristics and treatment patterns of children with ADHD, compare younger 
to older children within single age cohorts, and find seasonality and trends in dis-
parity of diagnosis and pharmacotherapy, within a non-selective real-world set-
ting. METHODS: Children aged 6-11 who were members of Clalit Health Services 
January 2010. Diagnosis (ICD-9 314.[0,1,2,8,9]) and medication (ATC codes ‘N06BAx’) 
were extracted from the Clalit Health Services database. Calendar months of first 
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OBJECTIVES: To evaluate the quality of life (QoL) of diabetic patients and its associ-
ated factors. METHODS: In January to Febrary 2014 patients with diabetes mellitus 
(DM) were interviewed in cities of Minas Gerais State about sociodemographic, clini-
cal and QoL aspects of. QoL was measured by the EuroQol questionnaire (Eq5D). 
Descriptive analysis, correlation, linear regression multivariate analyzes were per-
formed. RESULTS: We interviewed 2,620 patients. Of these, 69% were women, 84% 
had type 2 DM and 10% type 1. The mean age was 61 years (σ = 16). The descriptive 
system Eq5d scores ranged from -0.1896 and 1.000 (μ = 0.7158; σ = 0.22) and for the 
visual analog scale from 0 to 100 (μ = 67.5; σ = 22). These values are consistent with 
the utility values (-0.235 to 0.869) for the general population of Minas Gerais. The 
mean QoL of diabetic patients was 0.716 (σ = 0.22). Multivariate analysis showed that 
the following aspects significantly decrease QoL of the patients: (I) not being able to 
do usual activities; (II) bedridden for sickness; (III) worse self-rated health status; (IV) 
history of arthritis, osteoarthritis or rheumatism; (V) obesity; (VI) depression; (VII) 
stroke; (VIII) retinopathy; (IX) neuropathy; (X) chronic lung disease; (XI) thrombosis; 
(XII) need for help to take medicines; (XIII) growing old; (XIV) years on medication; 
(XV) living alone; (XVI) have been hospitalized in the last 15 days; (XVII) have spent 
money on supplies for diabetes and (XVIII) not do exercise (p < 0.05). CONCLUSIONS: 
The interviewed diabetic patients had worse QoL than the general population and 
the diabetes complications decreases QoL of these patients, which points out to the 
need for better disease control, monitoring and more educational activities that 
effectively contribute to the self-care.
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OBJECTIVES: Breast cancer is the most common cancer and the second highest cause 
of death due to cancer among women. The US Preventive Services Task Force and 
the American Association of Family Physicians recommend biennial mammography 
screening for women aged 50-74. This study is aimed at determining factors associ-
ated with mammography screening among women in this age group. METHODS: 
Women (50-74 years) who participated in the Behavioral Risk Factor Surveillance 
System in 2013 were included (n= 15,426). Weighted mammogram screening preva-
lence within the past two years was estimated and logistic regression was used to 
assess sociodemographic (age, race, marital status, education, income, healthcare 
coverage, employment), clinical (time since last routine check-up and pap smear, 
health status, history of cancer), and lifestyle (physical activity and smoking status) 
factors associated with mammogram screening. RESULTS: Most participants (77.4%) 
reported having a mammogram within the past 2 years. Factors associated with mam-
mogram screening within the past 2 years included: older age (ORs range: 1.26-1.57), 
higher income (ORs range: 1.23-1.50), having a health plan (OR= 2.63;95%CI= 2.22-
3.12), check-up within past year vs. 2 years or more (OR= 5.02;95%CI= 4.30-5.86), pap 
smear within past year vs. 5 years or more (OR= 9.25;95%CI= 8.01-10.69), history of 
cancer (OR= 1.23;95%CI= 1.08-1.39), being physically active (OR= 1.21;95%CI= 1.08-
1.36), and non-smoking (OR= 1.70;95%CI= 1.50-1.93). Blacks were more likely to screen 
than whites (OR= 1.69;95%CI= 1.40-2.04). Those with less than high school education 
were less likely to screen than those who attended college (OR= 0.81;95%CI= 0.66-
0.999). The retired were more likely to screen than those employed for wages 
(OR= 1.31;95%CI= 1.12-1.52). The unmarried were less likely to screen than the mar-
ried (OR= 0.79;95%CI= 0.70-0.90). CONCLUSIONS: Mammogram screening prevalence 
was below the 81.1% recommended by Healthy People 2020. Our findings identified 
population subgroups that may benefit from focused interventions. Policymakers 
may want to consider ensuring that patients have health insurance, regular check-
ups and pap smears.
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OBJECTIVES: Objectives of this study were to explore a) the effect of socio-demo-
graphic and personal characteristics on extent of discussions between men and 
healthcare providers about prostate specific antigen (PSA) testing and b) effect of 
discussions on PSA testing METHODS: This retrospective cross-sectional study ana-
lyzed data collected from the 2012 wave of the Behavioral Risk Factor Surveillance 
System (BRFSS). A discussion with providers about PSA testing was considered as 
a dependent variable. Baseline category logit model was used to measure effect of 
socio-demographic and personal variables on three levels of discussions (complete, 
partial and none). Logistic regression was used to test association between levels 
of discussion and whether a person had PSA test. RESULTS: Among 133,040 males, 
84996 (63.9%) said their providers discussed advantages of PSA with them, while 
94,818 (71.3%) said providers never discussed disadvantages of PSA testing. For 
46,971(35.3%), neither advantages nor disadvantages were discussed. Highest level 
of education, age, recommendation for having a PSA test by provider and having 
a unique personal provider were positively associated with discussions about PSA 
testing. Odds of not having a PSA test was at least 6.67 times (OR = 7.14, 95% CI = 6.67, 
7.69) more for those who had no discussion compared to those who had discussed 
either advantages or disadvantages and was less by at least 81% (OR = 0.18, 95% CI 
= 0.17, 0.19) for those who discussed both advantages and disadvantages compared 
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OBJECTIVES: This article presents results about risk management indicators per-
formed to HIC (Health Insurance Companies) for CKD (chronic kidney disease) and 
its precursor diseases based on the analysis of large databases achieved through 
the implementation of registry as public policy in Colombia. Also presents the 
economic incentives perceived by them thanks to the good results in risk man-
agement METHODS: CAC (Cuenta de Alto Costo) collects information from HIC in 
Colombia. By law, they report all patients diagnosed with HTA (hypertension),DM 
(diabetes) or CKD in a structure with 81 variables. After the data collection there 
is an audit process and finally, a database of approximately 3.050.000 records is 
obtained which is analyzed and allows the measurement of risk management 
indicators including: early diagnosis of CKD, effectiveness in clinical management, 
progression detention of CKD (less incidence) and calculating the prevalence of 
CKD5. RESULTS: The early diagnosis of CKD is the number of patients with HTA or 
DM studied for CKD corresponding to 38.25 %. The incidence of CKD5 corresponds 
to 11.01 per 100.000 affiliates. The effectiveness in clinical treatment correspond-
ing to the proportion of patient with controlled HTA is 66.54% and finally, the 
calculation of ERC5 prevalence corresponds to 668 ppm. With these results we 
can determine the economic incentives for risk management which is distrib-
uted among the country’s HIC corresponding to USD 44,284,255. CONCLUSIONS: 
Quality record of information as public policy, allows results based evaluation 
which improves attention quality. Of the 52 health insurance companies exist-
ing in Colombia, 25% exceed country risk management goals for all indicators 
and receive a larger sum of money for risk management. Risk management as a 
public policy in Colombia encourages results based competence and contributes 
to achieve savings in the attention of the disease through the implementation of 
nephroprotection programs.
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OBJECTIVES: We characterize healthcare utilization among congestive heart failure 
(CHF) patients in Israel who survived at least a year after diagnosis. METHODS: 
Adult members of a health maintenance organization in Israel (Maccabi Healthcare 
Services, MHS) who were diagnosed with CHF between January 2006 and December 
2012 were assessed. MHS databases are derived from electronic medical records of 
longitudinal data from a stable population of over 2 million and provide compre-
hensive clinical, demographic and health service data. RESULTS: Of 7691 eligible 
patients followed for 3 years after first diagnosis, 6357 (82.6%) survived ≥ 1year 
following diagnosis (mean age 72.7 years (SD 12.3 years)). During the first 6 months 
following diagnosis, these patients had, on average, 11.3 (SD 7.7), 2.8 (SD 3.0) and 
0.11 (SD 0.5) visits to their primary care physician, cardiologist, and nephrologist, 
respectively, and almost 70% had ≥ 1 hospital admission. Healthcare services use 
decreased after the first 6 months. Men were on average younger than women 
(70.2 vs. 76.0 years), had higher rates of cardiovascular comorbidity and saw a car-
diologist more often (p< 0.001) than women. More women had hypertension and 
chronic kidney disease but saw a nephrologist less often (p< 0.001) than men. In 
the first 6 months following diagnosis, women were hospitalized for longer periods 
than men (10.2 (SD 19.8) vs. 9.0 (SD 18.9) mean cumulative days of hospitalization, 
respectively). Similar trends were observed in primary care physician and hospital 
visits between genders. Patients surviving < 1 year from diagnosis tended to use 
outpatient services less often and inpatient services more often than ≥ 1 year sur-
vivors. CONCLUSIONS: Considerable resources are expended on CHF patients, with 
variations between male and female patients. Observations underscore the consid-
erable healthcare burden of CHF patients, apparent even in this Israeli population, 
diagnosis (2003-2011) and months of drug purchases (2010-2011) were compared 
by month of birth. Trends of diagnosis and treatment were determined for the vari-
ous sub-cohorts, and population sector differences were compared. RESULTS: Of 
total population (400,828 children, 51% male), 40467 (10.1%) were diagnosed with 
ADHD and 33188 (8.3%) were treated (usually methylphenidate). Diagnosis levels 
for younger (Y: Aug-Nov) children (10.9%) were lower than older (O: Dec, Jan-March) 
children (9.2%, RR 1.18 CI 1.16 to 1.21). The rate disparity was higher beginning 
school-year (September-December; RR 1.21 CI 1.17-1.26). Any-purchase dispensing 
RR was 1.19 (CI 1.16 to 1.22), while monthly RR was 1.18 (1.17-1.19). RR for dis-
pensing was stable between age-cohorts (1.17-1.22) without trend. Among children 
purchasing drugs, the seasonal variation in drug purchases (adherence) is similar 
Y:O CONCLUSIONS: ADHD diagnosis and medication are common in the primary 
school population. The increased incidence and prevalence among younger children 
in a cohort questions the appropriateness of both diagnosis and medication, sug-
gesting behavioral treatment may often be more suitable to avoid long term costs 
and deleterious effects, than pharmacological intervention.
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OBJECTIVES: Past experience using third party vendors to administer clinical pro-
grams for patients with chronic, progressive conditions resulted in low opt-in rates. 
A direct approach using the Specialty Pharmacy (SP) may have a better opt-in rate 
and compliance and persistence (C&P) with medication regimens. The objective of 
this interventional program administered by a specialty pharmacy (SP) [Accredo 
Specialty Pharmacy, Memphis, TN] was to evaluate a C&P program for bosentan 
(Actelion Pharmaceuticals Ltd., Allschwil, Switzerland) by comparing Pulmonary 
Arterial Hypertension (PAH) patients in the C&P program to a historical control 
group. METHODS: A pharmacist-based C&P program was administered directly 
by the SP that provided the medication and counseling, and patients were initially 
ranked using Morisky medication adherence scale to assess risk of non-adherence. 
Retrospective analysis was performed to measure program opt-in rate and C&P. 
Claims from a historical group (controls) and from the intervention group (cases) 
that received the SP-based C&P program between 04/29/2013 through 11/30/2013 
were analyzed. Claims for naïve users of bosentan were reviewed at 120 days and 
180 days for both persistence (bosentan claims not spaced > 45 days apart) and 
compliance (number of calendar days supplied with bosentan divided by 120 or 
180 days). Early refills were adjusted when considering days covered. Opt-in rates 
were also measured. RESULTS: Opt-in rate for the enhanced SP-based C&P program 
was robust at 97%. No statistically significant difference was seen between the 
control and case groups for persistence or compliance. Use of the Morisky scale 
to drive the number of pharmacist interventions did not impact outcomes in the 
case group. CONCLUSIONS: SP-based programs can achieve high participation that 
may drive medication compliance, which is essential in progressive diseases like 
PAH. Future programs should be SP-based to replicate the high opt-in rate while 
establishing new interventions to drive compliance and persistence.
PHS98
do PHarmaciStS’ barrierSâ€ ”incLuding non-reimburSement for non-
diSPenSing ServiceSâ€ ”infLuence tHe LeveL of adHerence Promotion 
activitieS for PerSonS Living WitH Hiv?
Kibicho J.
University of Wisconsin-Milwaukee, Milwaukee, WI, USA
OBJECTIVES: Despite significant advancements in antiretroviral therapy (ART), 
long-term consistent adherence to therapy remains a challenge for many persons 
living with HIV (PLWH). Pharmacists are well-positioned to promote adherence 
to ART beyond mandated dispensing services, but face many barriers, including 
non-reimbursement for adherence promotion activities (APA). Our study exam-
ines the extent to which pharmacists’ barriers (e.g., inadequate staff, no space) 
influence the level of APA in different pharmacy settings. METHODS: We test the 
hypothesis that pharmacists with fewer barriers provide fewer APA to PLWH, using 
generalized linear modelling (GLM). We use factor analysis to generate the APA index 
based on 38 APA (e.g., adherence assessment, customized interventions, monitoring 
activities). RESULTS: We surveyed 225 pharmacists from 41 U.S. states: (22% North 
East; 23% Midwest; 28% West; 27% South). The sample was mostly female (63%) 
Caucasian (66%), and > 30 years (67%). Most pharmacists had a HIV certification 
(68%); 31% worked in specialty-only and 21% in traditional-only pharmacies. Only 
26% of pharmacists reported APA-related reimbursements. Despite most pharma-
cists (95%) reporting > 5 barriers, the barriers index odds ratio (OR) was insignificant 
(OR: 1.007; p< .774). Insurance status [public vs. none (OR: 1.76 (p< .002) & private vs. 
none (OR: 1.90 p< .004)], pharmacy type [specialty vs. traditional (OR: 2.24 p< 0.001)] 
and HIV certification vs. none (OR: 3.65; p< .001) were significant predictors of APA. 
Interestingly, the OR of high volume (> 500 scripts/day) was significant only at 10% 
level (OR: 0.73 p< .07). CONCLUSIONS: The choice of pharmacy largely determines 
PLWH access to adherence promotion services from certified pharmacists. Our find-
ing that pharmacies that invest in HIV certification training are more likely to have 
higher levels of APA has implications for third party payers interested in adherence 
promotion as a cost containment strategy. Despite lack of reimbursement for adher-
ence promotion, many pharmacists are providing these important services to PLWH.
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